Search Results - "Guillot, Thomas S"

Refine Results
  1. 1
  2. 2

    Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons by Guillot, Thomas S, Miller, Gary W

    Published in Molecular neurobiology (01-04-2009)
    “…Vesicular monoamine transporters (VMATs) are responsible for the packaging of neurotransmitters such as dopamine, serotonin, norepinephrine, and epinephrine…”
    Get full text
    Journal Article
  3. 3

    Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration by Caudle, W. Michael, Richardson, Jason R, Wang, Min Z, Taylor, Tonya N, Guillot, Thomas S, McCormack, Alison L, Colebrooke, Rebecca E, Di Monte, Donato A, Emson, Piers C, Miller, Gary W

    Published in The Journal of neuroscience (25-07-2007)
    “…The vesicular monoamine transporter 2 (VMAT2; SLC18A2) is responsible for packaging dopamine into vesicles for subsequent release and has been suggested to…”
    Get full text
    Journal Article
  4. 4

    Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder by Richardson, Jason R., Taylor, Michele M., Shalat, Stuart L., Guillot, Thomas S., Caudle, W. Michael, Hossain, Muhammad M., Mathews, Tiffany A., Jones, Sara R., Cory‐Slechta, Deborah A., Miller, Gary W.

    Published in The FASEB journal (01-05-2015)
    “…ABSTRACT Attention‐deficit hyperactivity disorder (ADHD) is estimated to affect 8‐12% of school‐age children worldwide. ADHD is a complex disorder with…”
    Get full text
    Journal Article
  5. 5

    Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity by Lohr, Kelly M, Stout, Kristen A, Dunn, Amy R, Wang, Minzheng, Salahpour, Ali, Guillot, Thomas S, Miller, Gary W

    Published in ACS chemical neuroscience (20-05-2015)
    “…The psychostimulant methamphetamine (METH) is highly addictive and neurotoxic to dopamine terminals. METH toxicity has been suggested to be due to the release…”
    Get full text
    Journal Article
  6. 6

    Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized Mice by Stout, Kristen A, Dunn, Amy R, Lohr, Kelly M, Alter, Shawn P, Cliburn, Rachel A, Guillot, Thomas S, Miller, Gary W

    Published in ACS chemical neuroscience (19-10-2016)
    “…Drugs of abuse induce sensitization, which is defined as enhanced response to additional drug following a period of withdrawal. Sensitization occurs in both…”
    Get full text
    Journal Article
  7. 7

    Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis by Guillot, Thomas S, Shepherd, Kennie R, Richardson, Jason R, Wang, Min Z, Li, Yingjie, Emson, Piers C, Miller, Gary W

    Published in Journal of neurochemistry (01-09-2008)
    “…The vesicular monoamine transporter 2 (VMAT2) controls the loading of dopamine (DA) into vesicles and therefore determines synaptic properties such as quantal…”
    Get full text
    Journal Article
  8. 8
  9. 9

    PAP and NT5E Inhibit Nociceptive Neurotransmission by Rapidly Hydrolyzing Nucleotides to Adenosine by Street, Sarah E, Walsh, Paul L, Sowa, Nathaniel A, Taylor-Blake, Bonnie, Guillot, Thomas S, Vihko, Pirkko, Wightman, R Mark, Zylka, Mark J

    Published in Molecular pain (19-10-2011)
    “…Background: Prostatic acid phosphatase (PAP) and ecto-5'-nucleotidase (NT5E, CD73) produce extracellular adenosine from the nucleotide AMP in spinal…”
    Get full text
    Journal Article
  10. 10

    Polychlorinated Biphenyl–Induced Reduction of Dopamine Transporter Expression as a Precursor to Parkinson's Disease–Associated Dopamine Toxicity by Caudle, W. Michael, Richardson, Jason R., Delea, Kristin C., Guillot, Thomas S., Wang, Minzheng, Pennell, Kurt D., Miller, Gary W.

    Published in Toxicological sciences (01-08-2006)
    “…Epidemiological and laboratory studies have suggested that exposure to polychlorinated biphenyls (PCBs) may be a risk factor for Parkinson's disease. The…”
    Get full text
    Journal Article
  11. 11

    Pyrethroid pesticide-induced alterations in dopamine transporter function by Elwan, Mohamed A., Richardson, Jason R., Guillot, Thomas S., Caudle, W. Michael, Miller, Gary W.

    Published in Toxicology and applied pharmacology (15-03-2006)
    “…Parkinson's disease (PD) is a progressive neurodegenerative disease affecting the nigrostriatal dopaminergic pathway. Several epidemiological studies have…”
    Get full text
    Journal Article
  12. 12

    Industrial toxicants and Parkinson's disease by Caudle, W. Michael, Guillot, Thomas S., Lazo, Carlos R., Miller, Gary W.

    Published in Neurotoxicology (Park Forest South) (01-03-2012)
    “…The exposure of the human population to environmental contaminants is recognized as a significant contributing factor for the development of Parkinson's…”
    Get full text
    Journal Article
  13. 13

    Efficacy of Low-Level Laser Therapy for Body Contouring and Spot Fat Reduction by Caruso-Davis, Mary K., Guillot, Thomas S., Podichetty, Vinod K., Mashtalir, Nazar, Dhurandhar, Nikhil V., Dubuisson, Olga, Yu, Ying, Greenway, Frank L.

    Published in Obesity surgery (01-06-2011)
    “…Background Low-level laser therapy (LLLT) is commonly used in medical applications, but scientific studies of its efficacy and the mechanism by which it causes…”
    Get full text
    Journal Article
  14. 14

    Synapsins differentially control dopamine and serotonin release by Kile, Brian M, Guillot, Thomas S, Venton, B Jill, Wetsel, William C, Augustine, George J, Wightman, R Mark

    Published in The Journal of neuroscience (21-07-2010)
    “…Synapsins are a family of synaptic vesicle proteins that are important for neurotransmitter release. Here we have used triple knock-out (TKO) mice lacking all…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration by Alter, Shawn P., Stout, Kristen A., Lohr, Kelly M., Taylor, Tonya N., Shepherd, Kennie R., Wang, Minzheng, Guillot, Thomas S., Miller, Gary W.

    Published in Experimental neurology (01-01-2016)
    “…We previously demonstrated that mice with reduced expression of the vesicular monoamine transporter 2 (VMAT2 LO) undergo age-related degeneration of the…”
    Get full text
    Journal Article
  17. 17

    Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system by Hatcher, Jaime M., Richardson, Jason R., Guillot, Thomas S., McCormack, Alison L., Di Monte, Donato A., Jones, Dean P., Pennell, Kurt D., Miller, Gary W.

    Published in Experimental neurology (01-04-2007)
    “…Numerous epidemiological studies have shown an association between pesticide exposure and an increased risk of developing Parkinson's disease (PD). Here, we…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Chronically Implanted, Nafion-Coated Ag/AgCl Reference Electrodes for Neurochemical Applications by Hashemi, Parastoo, Walsh, Paul L, Guillot, Thomas S, Gras-Najjar, Julie, Takmakov, Pavel, Crews, Fulton T, Wightman, R. Mark

    Published in ACS chemical neuroscience (16-11-2011)
    “…Fast-scan cyclic voltammetry at carbon-fiber microelectrodes can be used to measure behaviorally correlated dopamine changes in the extracellular fluid of the…”
    Get full text
    Journal Article
  20. 20

    Optimizing the Temporal Resolution of Fast-Scan Cyclic Voltammetry by Kile, Brian M, Walsh, Paul L, McElligott, Zoé A, Bucher, Elizabeth S, Guillot, Thomas S, Salahpour, Ali, Caron, Marc G, Wightman, R. Mark

    Published in ACS chemical neuroscience (18-04-2012)
    “…Electrochemical detection with carbon-fiber microelectrodes has become an established method to monitor directly the release of dopamine from neurons and its…”
    Get full text
    Journal Article